1.77

2.91% 0.05

Silo Pharma Inc (SILO)

Overview News Price History Financials Discussions Forecast Stock Split

Silo Pharma Inc stock is traded at $1.77, with a volume of 43,867. It is up +2.91% in the last 24 hours and down -33.21% over the past month. SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Previous Close:

$1.72

Open:

$1.74

24h Volume:

43,867

Relative Volume:

0.24

Market Cap:

$3.10M

Revenue:

$72,100

Net Income/Loss:

$-4.84M

P/E Ratio:

-0.2374

EPS:

-7.4566

Net Cash Flow:

$-3.84M

1W Performance:

+0.57%

1M Performance:

-33.21%

6M Performance:

-66.06%

1Y Performance:

-85.53%

1-Day Range:

$1.74

$1.84

1-Week Range:

$1.66

$1.90

52-Week Range:

$1.63

$13.20

Silo Pharma Inc Stock (SILO) Company Profile

Name

Silo Pharma Inc

Sector

Healthcare (1066)

Industry

Biotechnology (595)

Phone

(718) 400-9031

Address

677 N. WASHINGTON BLVD, SARASOTA

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

SILO's Discussions on Twitter

Compare SILO vs MOBBW, PSNYW, GOODO, SHMD, CHAD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SILO SILO PHARMA INC	1.71	17.96M	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	1.49	1.98B	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	4.3101	706.40M	2.07B	-1.42B	-1.37B	-0.6765
GOODO Gladstone Commercial Corporation	20.19	372.90M	0	0	0	0.00
SHMD Schmid Group N V	3.68	239.23M	52.15M	-21.46M	0	-0.4675
CHAD Direxion Daily CSI 300 China A	8.90	197.39M	0	0	0	0.00

Silo Pharma Inc Stock (SILO) Latest News

Sep 18, 2026

Silo Pharma Secures U.S. Patent Allowance for PTSD Therapeutic SPC-15 - citybuzz -

Sep 18, 2026

Silo Pharma Inc (NASDAQ: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine

Sep 18, 2026

Silo Pharma receives U.S. patent allowance for PTSD treatment By Investing.com - Investing.com Canada

Sep 18, 2026

Silo Pharma Receives U.S. Patent Allowance For SPC-15 Ptsd Treatment - marketscreener.com

Sep 18, 2026

Silo Pharma Receives USPTO Notice of Allowance for SPC-15 Patent Covering Stress-Induced Behavioral Response Prevention - quiverquant.com

Sep 18, 2026

A PTSD treatment moves closer to U.S. patent protection - Stock Titan

Sep 18, 2026

Sep 11, 2026

SpaceX Stock Price Today | SPCX Ticker, News, Retail Sentiment - Stocktwits

Sep 11, 2026

Sep 10, 2026

Silo Pharma Inc (NYSE: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine

Sep 10, 2026

Sep 09, 2026

Silo Pharma Highlights Patented Nose-To-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum - marketscreener.com

Sep 09, 2026

Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting Progress of PTSD Candidate SPC-15 - citybuzz -

Sep 09, 2026

Silo Pharma to Participate in IPAC-RS 2026 Nasal Innovation Forum as It Advances SPC-15 Development - Quiver Quantitative

Sep 09, 2026